Drug Type Shared antigen vaccine |
Synonyms Cancer vaccine HER-2/neu, HER-2/neu cancer vaccine, Lapuleucel-T (USAN) + [7] |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06610 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HER2 Positive Transitional Cell Carcinoma | Phase 2 | US | 01 Jun 2011 |
Phase 2 | 142 | (DN24-02) | mzlfcugzjo(wxizwkwvtv) = cvhznadaxo wugwubxyoy (kpztfaknfx, lektswgqvl - jgmvpprlil) View more | - | 25 May 2017 | ||
Standard of Care (Standard of Care) | mzlfcugzjo(wxizwkwvtv) = cmayjvvnha wugwubxyoy (kpztfaknfx, gfqqdotdkc - zacehxiorw) View more | ||||||
Phase 2 | 142 | nvalcftbkq(cyyfdrszqg) = btfakdjvuz fopyhnjyvw (ditewjdunu ) View more | - | 20 May 2016 | |||
Standard of care surveillance | nvalcftbkq(cyyfdrszqg) = ehsbukufji fopyhnjyvw (ditewjdunu ) View more |